Alex C. Spyropoulos, MD, FACP, FCCP
Medical Director, Clinical Thrombosis Center, Lovelace Medical Center
Alex C. Spyropoulos, MD received his medical degree from the University of Pennsylvania School of Medicine in Philadelphia. He completed his internship and residency in internal medicine at the University of New Mexico Health Sciences Center in Albuquerque, NM. He is board certified in internal medicine. Dr. Spyropoulos is Founder and current Medical Director of the Clinical Thrombosis Center at Lovelace Health Systems in Albuquerque, New Mexico. As Clinical Associate Professor of Medicine and Associate Professor of Pharmacy at the University of New Mexico Health Sciences Center, he has developed a clinical thrombosis curriculum as part of the ambulatory medicine rotation. He is a Fellow of the American College of Physicians, American College of Chest Physicians, and International Academy of Clinical and Applied Thrombosis/Haemostasis. As a disease management consultant on anticoagulation in a managed care setting, Dr. Spyropoulos has been an integral member of Lovelace's Episode of Care disease management program on anticoagulation. He has helped to develop protocols using LMWH in outpatient-based treatment of venous thromboembolic disease, perioperative "bridging" for patients on chronic anticoagulation, post-operative DVT and medical inpatient prophylaxis, and protocols with regards to the use of direct thrombin inhibitors for HIT. Dr. Spyropoulos is active in assessing outcome analyses of these protocols, especially with regards to the implementation, safety, efficacy, and pharmacoeconomic indicators, and has lectured extensively both nationally and internationally on these issues. Dr. Spyropoulos' articles, letters, and editorials have been published in over 40 peer-reviewed journals including Chest, Journal of Thrombosis and Thrombolysis, Thrombosis Haemostasis, and Journal of Thrombosis Haemostasis.
Robert Rodvien, M.D., F.A.C.P.
Dr. Robert Rodvien is a Medical Director of the anticoagulation clinic at California Pacific Medical Center in San Francisco and chairs a Task Force on Bleeding and Thrombosis. Dr. Rodvien grew up in upper Manhattan where he attended Columbia University and Columbia University Medical Center. He completed his internship, medical residency and fellowship in hematology at Tufts University in Boston. After completing a postdoctoral fellowship in molecular biology at MIT and then a postdoctoral fellowship in biomaterials at Harvard/Beth Israel Hospital, Dr. Rodvien moved to San Francisco and has been on staff at CPMC for 35 years. During that time, Dr. Rodvien did basic and clinical research in thrombosis, worked in the Artificial Heart Program, was on an NIH study section in surgery and on several site visits for the NIH, and had a private practice in Hematology and Oncology. Most recently, Dr. Rodvien started a program to help patients help themselves by recording informative podcasts for those who have cancer or who are taking antithrombotic medicines.
Nitin Rohatgi MD, MBA
Nitin Rohatgi is board certified in Internal Medicine, Medical Oncology and Hematology. Dr. Rohatgi received his Masters of Business Administration at the Edinburg Business School in Scotland, UK. He earned his Medical Education from All India Institute of Medical Sciences in New Delhi, India. After finishing medical college in India, Dr. Rohatgi came to the United States to undergo specialty training through the Internal Medicine Internship and Residency Program at the University of Massachusetts, Memorial Medical Center. Following his residency, Dr. Rohatgi pursued further specialization in hematology-oncology with a fellowship in hematology and medial oncology at the University of Cincinnati Medical Center. Dr. Rohatgi has been affiliated with Sutter Medical Center, Sacramento as a private practice physician at Sacramento Center for Hematology and Medical Oncology since 2003. Dr. Rohatgi is a member of the American Society of clinical Oncology, American Society of Hematology, Sacramento Valley Medical Society and the California Medical Association.
Lawrence Wallace
Dr Lawrence N Wallace is a board certified Oral and Maxillofacial surgeon with over 25 years of private practice experience. He is a medical consultant to major medical insurance companies through his own consulting firm. His area of expertise is utilization and reimbursement. He is also involved in business development for various medical device companies and is currently president and CEO of his own medical device start up company. He lives in Carmel Valley CA and also in the San Francisco bay area.
Alan Wu, Ph.D., D.A.B.C.C.
Alan H.B. Wu, Ph.D., is Chief of Clinical Chemistry and Toxicology at San Francisco General Hospital and Professor of Laboratory Medicine, University of California, San Francisco. He received B.S. degrees in chemistry and biology at Purdue University, West Lafayette, Indiana, and a Ph.D. degree in analytical chemistry at the University of Illinois, Champaign-Urbana, Illinois. He completed a postdoctoral fellowship in clinical chemistry at Hartford Hospital. He is certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. Dr. Wu's research interest has been in three areas within the field of clinical chemistry laboratory. He has been involved at the national and international levels with development and use of biochemical markers for cardiovascular disease including CK-MB, myoglobin, troponin, B-type natriuretic peptide, and markers of myocardial ischemia, and stroke. As also has a long history of analytical, clinical, and forensic toxicology. In both of these areas, Dr. Wu has co-authored the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines. More recently, Dr. Wu has developed research and clinical programs in pharmacogenomics in support of the UCSF clinical pharmacogenomics laboratory. Among the areas of interest include pharmacogenomics for anticoagulants, especially warfarin, chemotherapeutics (tamoxefin, irinotecan), and drugs that can induce hypersensitivity reactions (abacavir, anticonvulsants).
Terry J. Wilk
Mr. Terry Wilk has over thirty years experience in health care information systems working for various health systems, consulting and IT vendor organizations. He is currently Vice President and Chief Information Officer for Henry Medical Center in Stockbridge, Georgia. Prior to his current position, Terry served as VP/CIO for Southern Regional Health System in Riverdale, GA; Fairview Health System (part of the Cleveland Clinic) in Cleveland, Ohio; and St. Vincent Medical Center in Toledo, Ohio. Terry holds a BBA from Cleveland State University and an MBA from Case Western Reserve University.
Theresa Lawrence-Ford
An Pang Chieng
|
